BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 12434420)

  • 61. Expression of HGF/SF and Met protein is associated with genetic alterations of VHL gene in primary renal cell carcinomas.
    Oh RR; Park JY; Lee JH; Shin MS; Kim HS; Lee SK; Kim YS; Lee SH; Lee SN; Yang YM; Yoo NJ; Lee JY; Park WS
    APMIS; 2002 Mar; 110(3):229-38. PubMed ID: 12076276
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Expression of angiopoietin-2 by human endometrial endothelial cells: regulation by hypoxia and inflammation.
    Krikun G; Schatz F; Finlay T; Kadner S; Mesia A; Gerrets R; Lockwood CJ
    Biochem Biophys Res Commun; 2000 Aug; 275(1):159-63. PubMed ID: 10944458
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Molecular targeting of VHL gene pathway in clear cell kidney cancer.
    Linehan WM
    J Urol; 2003 Aug; 170(2 Pt 1):593-4. PubMed ID: 12853837
    [No Abstract]   [Full Text] [Related]  

  • 64. Concomitant deregulation of HIF1alpha and cell cycle proteins in VHL-mutated renal cell carcinomas.
    Atkins DJ; Gingert C; Justenhoven C; Schmahl GE; Bonato MS; Brauch H; Störkel S
    Virchows Arch; 2005 Sep; 447(3):634-42. PubMed ID: 15991006
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Distinct von Hippel-Lindau gene and hypoxia-regulated alterations in gene and protein expression patterns of renal cell carcinoma and their effects on metabolism.
    Leisz S; Schulz K; Erb S; Oefner P; Dettmer K; Mougiakakos D; Wang E; Marincola FM; Stehle F; Seliger B
    Oncotarget; 2015 May; 6(13):11395-406. PubMed ID: 25890500
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Regulation of STRA13 by the von Hippel-Lindau tumor suppressor protein, hypoxia, and the UBC9/ubiquitin proteasome degradation pathway.
    Ivanova AV; Ivanov SV; Danilkovitch-Miagkova A; Lerman MI
    J Biol Chem; 2001 May; 276(18):15306-15. PubMed ID: 11278694
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A quantitative gene expression study suggests a role for angiopoietins in focal nodular hyperplasia.
    Paradis V; Bièche I; Dargère D; Laurendeau I; Nectoux J; Degott C; Belghiti J; Vidaud M; Bedossa P
    Gastroenterology; 2003 Mar; 124(3):651-9. PubMed ID: 12612904
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Renal cell carcinoma development in the rat independent of alterations at the VHL gene locus.
    Walker C; Ahn YT; Everitt J; Yuan X
    Mol Carcinog; 1996 Feb; 15(2):154-61. PubMed ID: 8599582
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Somatic mutations of VHL gene and HIF-1alpha expression in primary renal clear cell carcinomas].
    Guo HF; Gong K; Zou SM; Zhang ZW; Liu XY; Na X; Wu G; Na YQ
    Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(4):196-200. PubMed ID: 15062033
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: relationship to clinicopathological parameters.
    Kondo K; Yao M; Yoshida M; Kishida T; Shuin T; Miura T; Moriyama M; Kobayashi K; Sakai N; Kaneko S; Kawakami S; Baba M; Nakaigawa N; Nagashima Y; Nakatani Y; Hosaka M
    Genes Chromosomes Cancer; 2002 May; 34(1):58-68. PubMed ID: 11921283
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Molecular detection of von Hippel-Lindau gene mutations in urine and lymph node samples in patients with renal cell carcinoma: potential biomarkers for early diagnosis and postoperative metastatic status.
    Ashida S; Furihata M; Tanimura M; Sugita O; Yamashita M; Miura T; Moriyama M; Shuin T
    J Urol; 2003 Jun; 169(6):2089-93. PubMed ID: 12771725
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Downregulation of angiopoietin-1 and Tie2 in chronic hypoxic pulmonary hypertension.
    Yamamoto A; Takahashi H; Kojima Y; Tsuda Y; Morio Y; Muramatsu M; Fukuchi Y
    Respiration; 2008; 75(3):328-38. PubMed ID: 18073453
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The angiopoietins, tie2 and vascular endothelial growth factor are differentially expressed in the transformation of normal lung to non-small cell lung carcinomas.
    Wong MP; Chan SY; Fu KH; Leung SY; Cheung N; Yuen ST; Chung LP
    Lung Cancer; 2000 Jul; 29(1):11-22. PubMed ID: 10880843
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mutational analysis of the von hippel lindau gene in clear cell renal carcinomas from tuberous sclerosis complex patients.
    Duffy K; Al-Saleem T; Karbowniczek M; Ewalt D; Prowse AH; Henske EP
    Mod Pathol; 2002 Mar; 15(3):205-10. PubMed ID: 11904337
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of von Hippel-Lindau gene mutation and methylation status on expression of transmembrane carbonic anhydrases in renal cell carcinoma.
    Ashida S; Nishimori I; Tanimura M; Onishi S; Shuin T
    J Cancer Res Clin Oncol; 2002 Oct; 128(10):561-8. PubMed ID: 12384800
    [TBL] [Abstract][Full Text] [Related]  

  • 76. VHL-mediated hypoxia regulation of cyclin D1 in renal carcinoma cells.
    Bindra RS; Vasselli JR; Stearman R; Linehan WM; Klausner RD
    Cancer Res; 2002 Jun; 62(11):3014-9. PubMed ID: 12036906
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The von Hippel-Lindau tumor suppressor gene protects cells from UV-mediated apoptosis.
    Schoenfeld AR; Parris T; Eisenberger A; Davidowitz EJ; De Leon M; Talasazan F; Devarajan P; Burk RD
    Oncogene; 2000 Nov; 19(51):5851-7. PubMed ID: 11127815
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hypoxia-inducible factor-2alpha mRNA expression in human renal cell carcinoma.
    Sandlund J; Ljungberg B; Wikström P; Grankvist K; Lindh G; Rasmuson T
    Acta Oncol; 2009; 48(6):909-14. PubMed ID: 19322701
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Frequent somatic mutations of the von Hippel-Lindau tumor suppressor gene in primary sporadic human renal clear cell carcinomas].
    Gong K; Zhang Z; Xin D
    Zhonghua Yi Xue Za Zhi; 2001 Feb; 81(3):142-4. PubMed ID: 11798864
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Role of nuclear and cytoplasmic localization in the tumour-suppressor activity of the von Hippel-Lindau protein.
    Lewis MD; Roberts BJ
    Oncogene; 2003 Jun; 22(26):3992-7. PubMed ID: 12821933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.